- Report
- October 2025
- 197 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- March 2025
- 175 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- October 2025
- 160 Pages
Global
From €2962EUR$3,358USD£2,594GBP
€3485EUR$3,950USD£3,052GBP
- Report
- August 2025
- 154 Pages
Global
From €2175EUR$2,465USD£1,904GBP
€2559EUR$2,900USD£2,240GBP
- Report
- July 2025
- 150 Pages
Global
From €5249EUR$5,950USD£4,597GBP
- Report
- November 2025
- 188 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- October 2025
- 183 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 196 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 182 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 186 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 196 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 182 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 199 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 186 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €882EUR$1,000USD£773GBP
€1103EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €882EUR$1,000USD£773GBP
€1103EUR$1,250USD£966GBP
- Report
- December 2025
- 270 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- December 2025
- 340 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- May 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,974GBP
€4279EUR$4,850USD£3,747GBP
- Report
- February 2025
- 148 Pages
Global
From €3637EUR$4,123USD£3,185GBP
€4279EUR$4,850USD£3,747GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more